FDA, EMA Seek Biosimilar Pathway Convergence
This article was originally published in The Pink Sheet Daily
Executive Summary
The deputy director of FDA's Europe Office discusses the collaboration between FDA and the European Medicines Agency; the agencies are looking for ways to develop a common biosimilar development program.